Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Preclinical Evaluation of Lipid-Based Nanosystems
| Preclinical Evaluation of Lipid-Based Nanosystems |
| Autore | Silva Ana Catarina |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (351 p.) |
| Soggetto topico | Technology: general issues |
| Soggetto non controllato |
acoustic response
alopecia areata ammonia atopic dermatitis biocorona biodistribution Box‒Behnken design breast cancer Caco-2 monolayer cancer cholesterol clarithromycin colon cancer therapy cyanocobalamin D-optimal design dexamethasone dialysis dissolution enhancement docohexaenoic acid DoE doxorubicin drug delivery drug release efavirenz ethyl cellulose ex vivo permeation fenofibrate flaxseed oil fluconazole follicular targeting formulation optimization FZD10 protein hyaluronic acid hydrophobic ion pairing intestinal permeation enhancers intoxication ligand distribution light activation lipid phase lipid polymer hybrid nanocapsules lipid vesicles lipid-based formulation lipolysis lipomers liposome liposomes melanoma mesoporous silica microbubble mobility N-alkylisatin n/a nanocarrier nanoemulsion(s) nanomedicine nanostructured lipid carriers nanostructured lipid carriers (NLC) nanotransfersome nasal route neuroinflammation neuroprotection non-ionic surfactants nose-to-brain oligonucleotide optimization oral drug delivery PAI-2 permeation pharmacokinetics phase-behavior phospholipid coating phospholipids porous microparticles psoriasis quality by design (QbD) rheological behavior rivastigmine self-emulsifying drug delivery systems SerpinB2 silica-lipid hybrid skin skin topical delivery solid dosage forms solid lipid nanoparticles spray drying stability supersaturation target delivery nanosystem transferosomes ulcer index ultrasound contrast agents urokinase plasminogen activator vegetable oils vitamin B12 zone of inhibition |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557544303321 |
Silva Ana Catarina
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Recent Progress in Solid Dispersion Technology / Kohsaku Kawakami
| Recent Progress in Solid Dispersion Technology / Kohsaku Kawakami |
| Autore | Kawakami Kohsaku |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (204 p.) |
| Soggetto topico | Biology, life sciences |
| Soggetto non controllato |
thermodynamic modeling
molecular dynamics simulation poorly soluble drugs amorphous solid dispersions dissolution enhancement crystallization tendency continuous processing stability milling granulation thermal analysis amorphous ball milling pharmaceutical glass dissolution rebamipide poloxamer classification polyelectrolytes amorphisation self-assembly dissolution rate miscibility bioavailability solubility evaporation mesoporous polyelectrolyte excipient matrix polymer bicaludamide phase diagram Weibull dissolution model spectroscopic techniques anticancer drugs manufacturing methods nucleation molecular complex nanoaggregates enrofloxacin accelerated stability test solubility enhancement amorphous solid dispersion tadalafil process development amorphous polymeric salt Wood’s apparatus hot melt extrusion solid dispersions intrinsic dissolution rate solid dispersion interaction crystallization spray drying characterization ciprofloxacin |
| ISBN |
9783039215027
3039215027 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910367756203321 |
|
Kawakami Kohsaku
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||